» Articles » PMID: 32741102

Health-related Quality of Life After Anonymous Nondirected Living Liver Donation: A Multicenter Collaboration

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2020 Aug 3
PMID 32741102
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Literature on living nondirected liver donation is sparse. The purpose of this study was to assess health-related quality of life (HR-QOL) in anonymous nondirected living liver donors (ND-LLDs). ND-LLDs at 3 centers: University of Alberta (n = 12), University of Colorado (n = 12), and University of Southern California (n = 12), were surveyed. Thirty donors (83%) responded to the Donor Quality of Life (USC DQLS) and Short-Form 36 (SF-36). Most respondents (n = 15, 50%) donated their left lateral segment, 27% right lobe, and 23% left lobe. The majority were female (67%) and mean age was 38.9 ± 11.2 years at donation. Median follow-up was 1.1 (interquartile range 0.4-3.3) years. Approximately 37% had previously donated a kidney. Eleven experienced ≥1 postoperative complication, with only 1 Clavien-Dindo IIIb. Most reported minimal impact on school or work performance, all felt positive or neutral about their overall health since donation, and none expressed postdonation regrets. No donor reported impacts on health insurability, and 3 of 4 respondents attempting to purchase life insurance postdonation were successful. ND-LLD SF-36 outcomes were similar to US population norms. Overall, ND-LLDs demonstrated acceptable HR-QOL after donation and are appropriate candidates for partial liver donation. Based on evaluation of donation impact, consideration should be given to postdonation support strategies.

Citing Articles

The lived experience of living liver donors: A meta-synthesis of qualitative studies.

Dong L, Li Z, Lv F, Zheng L, Lu F BMC Nurs. 2024; 23(1):925.

PMID: 39702105 PMC: 11657966. DOI: 10.1186/s12912-024-02611-7.


Effect of Perioperative Dexmedetomidine on Delayed Graft Function Following a Donation-After-Cardiac-Death Kidney Transplant: A Randomized Clinical Trial.

Shan X, Hu L, Wang Y, Liu H, Chen J, Meng X JAMA Netw Open. 2022; 5(6):e2215217.

PMID: 35657627 PMC: 9166619. DOI: 10.1001/jamanetworkopen.2022.15217.


Anonymous Nondirected Living Liver Donation in the United States.

Raza M, Kaur N, Sher L, Genyk Y, Emamaullee J Transplant Direct. 2021; 8(1):e1275.

PMID: 34966843 PMC: 8710328. DOI: 10.1097/TXD.0000000000001275.


Health-Related Quality of Life in Predominantly Young Parental Living Liver Donors: A Cross-Sectional Study in China.

Shi Y, Zhang H, Chen J, Huang Y, Yu M, Jin Y Front Med (Lausanne). 2021; 8:726103.

PMID: 34660636 PMC: 8517132. DOI: 10.3389/fmed.2021.726103.


Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis.

Barbetta A, Butler C, Barhouma S, Hogen R, Rocque B, Goldbeck C Transplant Direct. 2021; 7(10):e767.

PMID: 34557584 PMC: 8454909. DOI: 10.1097/TXD.0000000000001219.

References
1.
Kim W, Lake J, Smith J, Schladt D, Skeans M, Noreen S . OPTN/SRTR 2017 Annual Data Report: Liver. Am J Transplant. 2019; 19 Suppl 2:184-283. DOI: 10.1111/ajt.15276. View

2.
Goldaracena N, Jung J, Aravinthan A, Abbey S, Krause S, Pritlove C . Donor outcomes in anonymous live liver donation. J Hepatol. 2019; 71(5):951-959. DOI: 10.1016/j.jhep.2019.06.027. View

3.
Reichman T, Fox A, Adcock L, Wright L, Abbey S, Levy G . Anonymous living liver donation: donor profiles and outcomes. Am J Transplant. 2010; 10(9):2099-104. DOI: 10.1111/j.1600-6143.2010.03244.x. View

4.
Abecassis M, Fisher R, Olthoff K, Freise C, Rodrigo D, Samstein B . Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant. 2012; 12(5):1208-17. PMC: 3732171. DOI: 10.1111/j.1600-6143.2011.03972.x. View

5.
Matas A, Garvey C, Jacobs C, Kahn J . Nondirected donation of kidneys from living donors. N Engl J Med. 2000; 343(6):433-6. DOI: 10.1056/NEJM200008103430611. View